Tyche Industries Limited (BOM:532384)
India · Delayed Price · Currency is INR 121.80
-4.20 (-3.33%)
At close: Jul 9, 2026
Tyche Industries Revenue
In the fiscal year ending March 31, 2026, Tyche Industries had annual revenue of 536.34M INR, down -19.01%. Tyche Industries had revenue of 161.95M in the quarter ending March 31, 2026, with 23.48% growth.
Revenue
536.34M
Revenue Growth
-19.01%
P/S Ratio
2.33
Revenue / Employee
3.31M
Employees
162
Market Cap
1.25B
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 536.34M | -125.87M | -19.01% |
| Mar 31, 2025 | 662.22M | -34.63M | -4.97% |
| Mar 31, 2024 | 696.84M | -59.16M | -7.83% |
| Mar 31, 2023 | 756.00M | 125.84M | 19.97% |
| Mar 31, 2022 | 630.16M | -163.86M | -20.64% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.72B |
| Kimia Biosciences | 1.15B |
| Panchsheel Organics | 1.07B |
| Smruthi Organics | 1.02B |
| Resonance Specialties | 902.48M |
| Vasundhara Rasayans | 357.23M |
| Accretion Nutraveda | 337.16M |
| Auro Laboratories | 307.40M |